Your browser doesn't support javascript.
loading
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
Matthey, Alain; Daali, Youssef; Curtin, François; Poncet, Antoine; Desmeules, Jules; Besson, Marie.
Afiliação
  • Matthey A; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Daali Y; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Curtin F; Faculty of Medicine, Geneva University, Geneva, Switzerland.
  • Poncet A; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Desmeules J; Faculty of Medicine, Geneva University, Geneva, Switzerland.
  • Besson M; Division of Clinical Epidemiology, Geneva University Hospitals, Geneva, Switzerland.
Eur J Pain ; 24(6): 1094-1106, 2020 07.
Article em En | MEDLINE | ID: mdl-32171038
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Clobazam / Hiperalgesia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur J Pain Assunto da revista: NEUROLOGIA / PSICOFISIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Clobazam / Hiperalgesia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur J Pain Assunto da revista: NEUROLOGIA / PSICOFISIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça